Fenofibrate as a Metabolic Intervention for Coronavirus Disease 2019 (COVID-19): A Randomized Controlled Trial

December 30, 2020 | Hospital-Based, Community/Outpatient Based | 

Hospital and community/outpatient-based; 160 mg/d, administered for 10 days

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!